Pharmacokinetics and bioavailability of methocarbamol in rats

Authors:

Abstract
In a pharmacokinetic study, 15, 30, 60, and 150 mg kg−1 intravenous and oral doses of methocarbamol were administered to rats. Differences observed in plasma clearance values, i.e. 0.0203, 0.0156, 0.0123, and 0.0085 1 kg−1 min−1 for 15, 30,60, and 150 mg kg−1, respectively, suggested a dose-dependent pharmacokinetic behaviour of the drug. Elimination according to a biocompartmental open model and Michaelis-Menten kinetics fits the plasma level data. Estimated Km and Vmax values were 38.49 ± 3.71 mg l−1 and 1.24 ± 0.06 mg l−1 min−1, respectively. After oral administration of 15, 30, and 60 mg kg−1 the peak plasma levels were reached earlier. The tmax values were 6, 6, and 10 min, respectively. After 150 mg kg−1 oral doses, peak plasma levels were reached later (tmax = 150 min). Estimated bioavailability ranged between 77 and 112 per cent.

This publication has 9 references indexed in Scilit: